BioCorRx (BICX) Amortization of Deferred Charges (2015 - 2025)

BioCorRx's (BICX) quarterly Amortization of Deferred Charges came in at $1877.0 in Q4 2025, down 98.15% year-on-year from $101725.0 in Q4 2024, and down 96.33% quarter-over-quarter from $51198.0 in Q1 2025.

BioCorRx (BICX) Amortization of Deferred Charges (2015 - 2025) Analysis & Trends

BioCorRx has disclosed Amortization of Deferred Charges across 5 years of filings, most recently posting $1877.0 for Q4 2025.

  • Amortization of Deferred Charges for Q4 2025 came in at $1877.0, down 98.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $154800.0 (up 1.23% YoY), and the FY2025 annual result was $55738.0, down 91.03% from the prior year.
  • Amortization of Deferred Charges came in at $1877.0 for Q4 2025 at BioCorRx, down from $51198.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $101725.0 in Q4 2024 to a low of $1877.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 83.85 Bn 86.23 Bn 16.26 Bn
2 Tenet Healthcare 14.98 Bn 14.15 Bn 4.41 Bn
3 Davita 13.99 Bn 14.84 Bn 1.07 Bn
4 Encompass Health 9.72 Bn 10.34 Bn 1.34 Bn
5 Ensign 8.90 Bn 8.31 Bn 293.37 Mn
6 Universal Health Services 8.59 Bn 8.55 Bn 3.21 Bn
7 Fresenius Medical Care AG 7.67 Bn 5.29 Bn -4.26 Bn
8 Chemed 5.97 Bn 5.96 Bn 215.76 Mn
9 Pacs 5.74 Bn 5.50 Bn 345.96 Mn
10 BioCorRx - - 189,355.00

Historic Data

Download Data
DateValue
Dec 31, 2025 1,877.00
Dec 31, 2025 1,877.00
Mar 31, 2025 51,198.00
Mar 31, 2025 51,198.00
Dec 31, 2024 101,725.00
Dec 31, 2024 101,725.00
Mar 31, 2017 9.36 Mn
Mar 31, 2017 9.36 Mn
Dec 31, 2016 45,152.00
Dec 31, 2016 45,152.00
Mar 31, 2016 21,722.00
Mar 31, 2016 21,722.00
Dec 31, 2015 35,488.00
Dec 31, 2015 35,488.00
Sep 30, 2015 48,234.00
Sep 30, 2015 48,234.00
Jun 30, 2015 14,966.00
Jun 30, 2015 14,966.00
Mar 31, 2015 71,354.00
Mar 31, 2015 71,354.00